IMMUNOCORE HLDGS PLC's ticker is IMCR and the CUSIP is 45258D105. A total of 48 filers reported holding IMMUNOCORE HLDGS PLC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,406,457 | -1.9% | 65,635 | +13.3% | 0.02% | +8.7% |
| Q2 2023 | $3,473,903 | +228.0% | 57,937 | +170.5% | 0.02% | +283.3% |
| Q1 2023 | $1,059,054 | -77.9% | 21,421 | -74.5% | 0.01% | -78.6% |
| Q4 2022 | $4,792,910 | +101.5% | 83,983 | +65.7% | 0.03% | +115.4% |
| Q3 2022 | $2,379,000 | +51.8% | 50,688 | +20.7% | 0.01% | +30.0% |
| Q2 2022 | $1,567,000 | +7361.9% | 42,009 | +6006.0% | 0.01% | – |
| Q1 2022 | $21,000 | +10.5% | 688 | +37.6% | 0.00% | – |
| Q3 2021 | $19,000 | – | 500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 576,923 | $24,560,000 | 4.02% |
| Rock Springs Capital Management LP | 2,292,285 | $97,583,000 | 2.13% |
| RTW INVESTMENTS, LP | 1,245,532 | $50,142,000 | 0.78% |
| Avidity Partners Management LP | 550,000 | $23,414,000 | 0.65% |
| Samsara BioCapital, LLC | 80,000 | $3,406,000 | 0.63% |
| Bain Capital Public Equity Management II, LLC | 300,871 | $12,808,000 | 0.53% |
| GENERAL ATLANTIC, L.P. | 950,000 | $40,442,000 | 0.47% |
| Baker Brothers Advisors | 2,520,730 | $107,307,000 | 0.46% |
| Perceptive Advisors | 400,000 | $17,028,000 | 0.22% |
| Pinz Capital Management, LP | 18,700 | $796,000 | 0.21% |